Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism CSPG4 gene modulators(chondroitin sulfate proteoglycan 4 gene modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | GB | 22 Apr 2020 |